m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii

艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白

基本信息

项目摘要

Toxoplasma gondii is an intracellular parasite that causes life-threatening opportunistic infection in HIV/AIDS patients. The replicative stage (tachyzoite) develops into a latent stage (bradyzoite) that is impervious to immunity and approved antiparasitic drugs. Tissue cysts give rise to recurrent reactivation of infection in the immunocompromised, creating chronic disease in HIV/AIDS patients. Compounding this problem is a paucity of safe and effective therapies, which underscores the urgent need to identify essential processes in the parasite that could be exploited for the development of better drugs. We and others recently discovered that methylation of adenosines at position 6 (m6A) is abundant in Toxoplasma mRNA, representing a new layer of gene regulation called epitranscriptomics. Importantly, the proteins that “write” and “read” m6A modifications are essential for parasite viability. Moreover, as this machinery resembles plants more than humans, it represents an attractive new drug target. To study this vulnerability in Toxoplasma, we aim to fill the gap in our knowledge regarding how this signal dictates the fate of mRNA transcripts through the study of m6A reader proteins. We hypothesize that Toxoplasma m6A mRNA reader proteins coordinate different aspects of mRNA metabolism essential for parasite viability. In other species, m6A readers are found in the nucleus and cytosol, regulating the fate of mRNA by modulating splicing, trafficking, and translation. To date, only two nuclear YTH family m6A readers have been identified and they remain largely uncharacterized. And, despite the abundance of m6A mRNA in the cytosol, no cytosolic m6A readers have been identified. We propose two specific aims that will address our hypothesis by answering these questions. Aim 1 will determine the roles of the two plant-like YTH m6A readers operating in the Toxoplasma nucleus. Aim 2 will identify novel m6A reader proteins from tachyzoites and bradyzoites using a functional m6A-binding probe that we developed. These pioneering studies will mark the first detailed analysis of m6A readers in both replicative and latent stages of Toxoplasma, which promises to reveal new therapeutic options to treat this opportunistic infection of HIV/AIDS patients.
刚地弓形虫是一种细胞内寄生虫,可引起危及生命的机会性感染

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William J Sullivan其他文献

William J Sullivan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William J Sullivan', 18)}}的其他基金

Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons
驱动弓形虫缓殖子在神经元中持续存在的翻译起始因子
  • 批准号:
    10556561
  • 财政年份:
    2022
  • 资助金额:
    $ 19.51万
  • 项目类别:
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma
艾滋病机会病原体弓形虫包囊形成的调节
  • 批准号:
    10515665
  • 财政年份:
    2021
  • 资助金额:
    $ 19.51万
  • 项目类别:
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma
艾滋病机会病原体弓形虫包囊形成的调节
  • 批准号:
    10401525
  • 财政年份:
    2021
  • 资助金额:
    $ 19.51万
  • 项目类别:
Eradicating latent toxoplasmosis
根除潜伏弓形虫病
  • 批准号:
    10116280
  • 财政年份:
    2020
  • 资助金额:
    $ 19.51万
  • 项目类别:
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫的表观转录组学
  • 批准号:
    9763130
  • 财政年份:
    2019
  • 资助金额:
    $ 19.51万
  • 项目类别:
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫的表观转录组学
  • 批准号:
    9889878
  • 财政年份:
    2019
  • 资助金额:
    $ 19.51万
  • 项目类别:
Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS
弓形虫(HIV/AIDS 的一种机会性感染)阶段转换过程中的转化控制
  • 批准号:
    9226018
  • 财政年份:
    2016
  • 资助金额:
    $ 19.51万
  • 项目类别:
Translational Control of Encystation in the Entamoebae
内阿米巴包囊的翻译控制
  • 批准号:
    8913307
  • 财政年份:
    2015
  • 资助金额:
    $ 19.51万
  • 项目类别:
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis
抑制磷酸酶活性作为慢性弓形体病的新治疗方法
  • 批准号:
    8719806
  • 财政年份:
    2013
  • 资助金额:
    $ 19.51万
  • 项目类别:
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis
抑制磷酸酶活性作为慢性弓形体病的新治疗方法
  • 批准号:
    8504211
  • 财政年份:
    2013
  • 资助金额:
    $ 19.51万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 19.51万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了